Simone Heyn

The Induction Regimen Does Not Affect Stem-Cell Collection in Adult Patients with Ewing Sarcoma

Anne-Marie Scheuble, Simone Heyn, Enrica Bach, Clara Pohl et autres

Associations between CT Radiomics Analyses and Hematopoietic Cell Mobilization in Patients with Multiple Myeloma: An Exploratory Analysis

Jakob Leonhardi, Tihomir Dermendzhiev, Enrica Bach, Mandy Brückner et autres

de (code pays fourni par la source)

Associations between CT Radiomics Analyses and Hematopoietic Cell Mobilization in Patients with Multiple Myeloma: An Exploratory Analysis

Jakob Leonhardi, T. Dermendjiev, Enrica Bach, Mandy Brückner et autres

Impact of Renal Impairment and Lymphodepletion Regimen on Outcomes after CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma

Nora Grieb, Thomas Wiemers, Patrick Born, David Fandrei et autres

de, us (code pays fourni par la source)

Spatiotemporal and genetic tracking of long-term persisting CAR-T cells following ciltacabtagene autoleucel treatment for multiple myeloma reveals molecular insights into late-onset toxicities

David Fandrei, Sabine Seiffert, Christina Katharina Kuhn, Michael Rade et autres

de, nl, us (code pays fourni par la source)

Splenomegaly is Associated with High-Tumor Burden, Prolonged Cytopenia and Adverse Outcome after BCMA-directed CAR T-Cell Therapy

Thomas Wiemers, Maximilian Ferle, Veronika Sotikova, David Fandrei et autres

Prognostic Implications of Splenomegaly in BCMA-Directed CAR T-Cell Therapy for Relapsed Myeloma

Thomas Wiemers, Maximilian Ferle, Veronika Sotikova, David Fandrei et autres

de (code pays fourni par la source)

716 | CD19‐DIRECTED CHIMERIC ANTIGEN RECEPTOR‐CELL THERAPY FOR B‐CELL LYMPHOMAS WITH PRIMARY OR SECONDARY CNS INVOLVEMENT. REAL‐WORLD DATA FROM A MULTICENTER ANALYSIS

Georg‐Nikolaus Franke, Ulf Schnetzke, Vanja Zeremski, Madlen Jentzsch et autres

de, us (code pays fourni par la source)

159 | R‐POLA‐GLO – CHEMO‐LIGHT FRONTLINE THERAPY INDUCES HIGH RESPONSE RATES WITH A FAVORABLE SAFETY PROFILE IN ELDERLY/FRAIL PATIENTS WITH AGGRESSIVE LYMPHOMA

Rebecca Wurm‐Kuczera, Thomas Melchardt, P. Pichler, A. Huster et autres

de, at (code pays fourni par la source)

Prognostic implications of splenomegaly in BCMA-directed CAR T-Cell therapy for relapsed myeloma

Thomas Wiemers, Maximilian Ferle, Veronika Sotikova, David Fandrei et autres

de, us (code pays fourni par la source)

Supplementary Table 1 from Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma

David Fandrei, Sabine Seiffert, Michael Rade, Susanne Rieprecht et autres

Data from Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma

David Fandrei, Sabine Seiffert, Michael Rade, Susanne Rieprecht et autres